Click here to discover the largest collection of GeneMedi's Promise-ORF™ ORF/cDNA expression clones
- • Up to 20%-50%* off first purchase
- • Bulk quantities available
- • Citation Reward application
TECHNICAL RESOURCE
Supports
- Talk to our Expert:
[email protected]
Protocol Library Download
 |
 |
Human CREB1/CREB/CREB-1 ORF/cDNA clone-Adenovirus particle (NM_134442)
Cat. No.: vGMAP-SPh-270
Pre-made Human CREB1/CREB/CREB-1 Adenovirus for CREB1 overexpression in-vitro and in-vivo. The CREB1 adenoviral vector excels as a vehicle for transient gene transfection in both stable cell lines and primary cells, including DC cells, macrophages, cardiomyocytes, hepatocytes, and neurons. The purified CREB1-encoding adenovirus also stands out as a quintessential tool for in vivo studies and vaccine research initiatives.
At GM Vector Core (GMVC), we provide bespoke adenovirus development and manufacture various grades of adenoviruses utilizing cutting-edge techniques. Dive deeper into our offerings.
Go to
CREB1/CREB products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
MSDS
Product information
| Catalog No. | Product Name | Adenovirus Grade | Adenovirus quantity |
| vGMAP-SPh-270 | Human CREB1 Adenovirus particle | Research Grade-In vitro | 1E+10PFU (1E+10pfu/ml×1ml) |
| 5E+10PFU (1E+10pfu/ml×5ml) | |||
| 1E+11PFU (1E+10pfu/ml×10ml) | |||
| Research Grade-In vivo | 1E+11PFU (1E+11pfu/ml×1ml) | ||
| GMP-like Grade | inquiry | ||
| GMP Grade | inquiry |
Product Description
| Catalog ID | vGMAP-SPh-270 |
| Gene Name | CREB1 |
| Accession Number | NM_134442 |
| Gene ID | 1385 |
| Species | Human |
| Product Type | Adenovirus particle (overexpression) |
| Insert Length | 1026 bp |
| Gene Alias | CREB,CREB-1 |
| Fluorescent Reporter | EGFP |
| Mammalian Cell Selection | Null |
| Fusion Tag | 3xflag (C-Terminal) |
| Promoter | EF1 |
| Resistance | Amplicin |
| ORF Nucleotide Sequence | ATGACCATGGAATCTGGAGCCGAGAACCAGCAGAGTGGAGATGCAGCTGTAACAGAAGCTGAAAACCAACAAATGACAGTTCAAGCCCAGCCACAGATTGCCACATTAGCCCAGGTATCTATGCCAGCAGCTCATGCAACATCATCTGCTCCCACCGTAACTCTAGTACAGCTGCCCAATGGGCAGACAGTTCAAGTCCATGGAGTCATTCAGGCGGCCCAGCCATCAGTTATTCAGTCTCCACAAGTCCAAACAGTTCAGTCTTCCTGTAAGGACTTAAAAAGACTTTTCTCCGGAACACAGATTTCAACTATTGCAGAAAGTGAAGATTCACAGGAGTCAGTGGATAGTGTAACTGATTCCCAAAAGCGAAGGGAAATTCTTTCAAGGAGGCCTTCCTACAGGAAAATTTTGAATGACTTATCTTCTGATGCACCAGGAGTGCCAAGGATTGAAGAAGAGAAGTCTGAAGAGGAGACTTCAGCACCTGCCATCACCACTGTAACGGTGCCAACTCCAATTTACCAAACTAGCAGTGGACAGTATATTGCCATTACCCAGGGAGGAGCAATACAGCTGGCTAACAATGGTACCGATGGGGTACAGGGCCTGCAAACATTAACCATGACCAATGCAGCAGCCACTCAGCCGGGTACTACCATTCTACAGTATGCACAGACCACTGATGGACAGCAGATCTTAGTGCCCAGCAACCAAGTTGTTGTTCAAGCTGCCTCTGGAGACGTACAAACATACCAGATTCGCACAGCACCCACTAGCACTATTGCCCCTGGAGTTGTTATGGCATCCTCCCCAGCACTTCCTACACAGCCTGCTGAAGAAGCAGCACGAAAGAGAGAGGTCCGTCTAATGAAGAACAGGGAAGCAGCTCGAGAGTGTCGTAGAAAGAAGAAAGAATATGTGAAATGTTTAGAAAACAGAGTGGCAGTGCTTGAAAATCAAAACAAGACATTGATTGAGGAGCTAAAAGCACTTAAGGACCTTTACTGCCACAAATCAGATTAA |
| ORF Protein Sequence | MTMESGAENQQSGDAAVTEAENQQMTVQAQPQIATLAQVSMPAAHATSSAPTVTLVQLPNGQTVQVHGVIQAAQPSVIQSPQVQTVQSSCKDLKRLFSGTQISTIAESEDSQESVDSVTDSQKRREILSRRPSYRKILNDLSSDAPGVPRIEEEKSEEETSAPAITTVTVPTPIYQTSSGQYIAITQGGAIQLANNGTDGVQGLQTLTMTNAAATQPGTTILQYAQTTDGQQILVPSNQVVVQAASGDVQTYQIRTAPTSTIAPGVVMASSPALPTQPAEEAARKREVRLMKNREAARECRRKKKEYVKCLENRVAVLENQNKTLIEELKALKDLYCHKSD |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
|---|---|---|
| Target Antibody | GM-Tg-g-T92098-Ab | Anti-CREB1 monoclonal antibody |
| Target Antigen | GM-Tg-g-T92098-Ag | CREB1 protein |
| ORF Viral Vector | pGMLP002666 | Human CREB1 Lentivirus plasmid |
| ORF Viral Vector | pGMLP-SPh-130 | Human CREB1 Lentivirus plasmid |
| ORF Viral Vector | pGMAP-SPh-270 | Human CREB1 Adenovirus plasmid |
| ORF Viral Vector | pGMPC001174 | Human CREB1 Mammalian (Non-Viral Vector) plasmid |
| ORF Viral Vector | pGMPC001332 | Human CREB1 Mammalian (Non-Viral Vector) plasmid |
| ORF Viral Vector | vGMLP002666 | Human CREB1 Lentivirus particle |
| ORF Viral Vector | vGMLP-SPh-130 | Human CREB1 Lentivirus particle |
| ORF Viral Vector | vGMAP-SPh-270 | Human CREB1 Adenovirus particle |
Target information
| Target ID | GM-T92098 |
| Target Name | CREB1 |
|
Gene Group Identifier （Target Gene ID in Homo species) |
1385 |
| Gene ID |
100066388 (Equus caballus), 101091299 (Felis catus), 12912 (Mus musculus), 1385 (Homo sapiens) 281713 (Bos taurus), 607922 (Canis lupus familiaris), 708717 (Macaca mulatta), 81646 (Rattus norvegicus) |
| Gene Symbols & Synonyms | CREB1,Creb1,Creb,Creb-1,2310001E10Rik,3526402H21Rik,CREB,CREB-1 |
| Target Alternative Names | 2310001E10Rik,3526402H21Rik,CREB,CREB-1,CREB1,Creb,Creb-1,Creb1,Cyclic AMP-responsive element-binding protein 1,cAMP-responsive element-binding protein 1 |
| Uniprot Accession |
P15337,P16220,P27925,Q01147
Additional SwissProt Accessions: Q01147,P16220,P27925,P15337 |
| Uniprot Entry Name | |
| Protein Sub-location | Introcelluar Protein |
| Category | Therapeutics Target |
| Disease | cancer |
| Disease from KEGG | cGMP-PKG signaling pathway, cAMP signaling pathway, PI3K-Akt signaling pathway, Longevity regulating pathway, Adrenergic signaling in cardiomyocytes, Osteoclast differentiation, Antigen processing and presentation, TNF signaling pathway, Circadian entrainment, Cholinergic synapse, Insulin secretion, Melanogenesis, Thyroid hormone synthesis, Renin secretion, Aldosterone synthesis and secretion, Relaxin signaling pathway, Cortisol synthesis and secretion, Parathyroid hormone synthesis, secretion and action, Insulin resistance, Cushing syndrome, Growth hormone synthesis, secretion and action, Cocaine addiction, Amphetamine addiction, Tuberculosis, Hepatitis B, Human cytomegalovirus infection, Human papillomavirus infection, Human T-cell leukemia virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Chemical carcinogenesis - receptor activation, Prostate cancer |
| Gene Ensembl | ENSECAG00000013667, ENSMUSG00000025958, ENSG00000118260, ENSBTAG00000005474, ENSCAFG00845022020, ENSMMUG00000022601 |
| Target Classification | Tumor-associated antigen (TAA) |
About GMVC
GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.